Amidst rising cancer rates, particularly among the youth, Dr. Jayesh Sharma clarifies the link between soy consumption and breast cancer risk. Soybeans, rich in nutrients and phytoestrogens, have been ...

This precision medicine approach, driven by granular, real-world evidence, is critical for reshaping clinical guidelines and ...

Talk about a heavy lift. A 22-year-old Brazilian woman has a new lease on life after surgeons removed 22 pounds of excess ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

If patients with breast cancer hyperglycemia or symptoms of it at home, a short break from capivasertib may be required, according to Hope Rugo, MD.

“Laser facial resurfacing stimulates collagen production in the skin, which helps minimize fine lines and other effects of ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Prolonged daily sitting is linked to a higher prevalence of breast cancer in obese women, but only among those who are ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

Bebe Buell turns 72 today, and the rock & roll grand dame has never been more vital. Or more appreciative of her time on this planet. Last summer, the singer, songwriter, and model was diagnosed with ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...